California-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000

California-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000

Submitted by admin on December 28, 2018 - 1:19pm
Source: 
BioSpace
News Tags: 
Opiant Pharmaceuticals
Sanofi
cannabinoid overdose
drinabant
Headline: 
California-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000
snippet: 

Overdose and drug addiction specialist Opiant Pharmaceuticals struck a licensing deal with Sanofi for the development and commercialization of a late-stage-ready treatment for acute cannabinoid overdose.

Do Not Allow Advertisers to Use My Personal information